Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Brunico Hospital (SABES - ASDAA)

Research site

Italy Spitalstrasse 11, 39031 Brunico, Italy

  • Polymyalgia rheumatica · Psoriatic arthropathy
  • Adult patients

About Specializations

Brunico Hospital (SABES - ASDAA) in Brunico, Italy specialises in clinical trials of conditions such as Polymyalgia rheumatica, Psoriatic arthropathy, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for inflammatory conditions. The center's work in this field is exemplified by its exploration of new therapeutic approaches for polymyalgia rheumatica, a condition characterized by muscle pain and stiffness.

  • Polymyalgia Rheumatica
  • Glucocorticoid-Sparing Regimens
  • Remission-Induction Therapies

Through rigorous clinical trials, the center aims to enhance patient outcomes by developing glucocorticoid-sparing regimens that reduce dependency on traditional treatments, thereby minimizing side effects and improving quality of life for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Spitalstrasse 1139031 BrunicoItaly
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in BrunicoItaly

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Psoriatic arthropathy

Not yet recruiting

A Study of Guselkumab and Ciclosporin in Patients with Early Psoriatic Arthritis Transitioning from Skin to Joint Disease

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ciclosporin
  • Sponsor:Azienda Sanitaria Universitaria Friuli Centrale

Polymyalgia rheumatica

Not recruiting

Study on Baricitinib for New-Onset Polymyalgia Rheumatica Patients to Reduce Steroid Use

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Medical University Of Vienna
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.